Veradigm Inc. (NASDAQ:MDRX – Get Free Report) has been given an average rating of “Hold” by the five ratings firms that are covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $11.25.
MDRX has been the topic of several recent analyst reports. Barclays started coverage on Veradigm in a report on Wednesday, January 3rd. They issued an “equal weight” rating and a $11.00 target price on the stock. StockNews.com assumed coverage on shares of Veradigm in a research report on Monday. They issued a “hold” rating on the stock. Royal Bank of Canada reduced their target price on Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a report on Friday, January 19th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a $10.00 price target (down previously from $15.00) on shares of Veradigm in a research note on Tuesday, March 19th.
Read Our Latest Stock Report on MDRX
Institutional Inflows and Outflows
Veradigm Price Performance
Shares of Veradigm stock opened at $7.55 on Friday. The company’s fifty day moving average price is $7.81 and its two-hundred day moving average price is $10.16. Veradigm has a 52-week low of $5.01 and a 52-week high of $14.09.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Comprehensive PepsiCo Stock Analysis
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Bear Market Funds to Watch This Year
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.